Literature DB >> 22364327

Prevalence, clinical features and potential therapies for fibromyalgia in primary headaches.

Marina de Tommaso1.   

Abstract

Fibromyalgia (FM) syndrome is predominantly related to generation and persistence of central sensitization, which is an aggravating factor for chronic headaches. This review aims to examine the last 11 years of studies on FM and primary headache comorbidity, focusing on prevalence, clinical features and treatments. Chronic forms of migraine and tension-type headache show a high frequency of FM comorbidity. The symptoms characterizing headache patients presenting with FM comorbidity are high headache frequency, poor sleep quality, pericranial tenderness, anxiety and reduction of physical performances. The effects of headache-preventive drugs on factors favoring FM comorbidity were poorly evaluated. Nonpharmacological approaches such as transcranial magnetic stimulation may be an option for treatment of chronic migraine associated with FM.

Entities:  

Mesh:

Year:  2012        PMID: 22364327     DOI: 10.1586/ern.11.190

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  11 in total

1.  Fibromyalgia comorbidity in a community sample of adults with migraine.

Authors:  Dawn A Marcus; Amrita Bhowmick
Journal:  Clin Rheumatol       Date:  2013-06-07       Impact factor: 2.980

2.  Nociceptive blink reflex habituation biofeedback in migraine.

Authors:  M de Tommaso; M Delussi
Journal:  Funct Neurol       Date:  2017 Jul/Sep

3.  Effectiveness of peripheral nerve blockage on the symptoms of both diseases in patients with fibromyalgia and chronic migraine coexistence.

Authors:  Gokhan Evcili; Ahmet Yabalak
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-08       Impact factor: 1.712

4.  Quality of life and emotional functioning in youth with chronic migraine and juvenile fibromyalgia.

Authors:  Susmita Kashikar-Zuck; Marium Zafar; Kimberly A Barnett; Brandon S Aylward; Daniel Strotman; Shalonda K Slater; Janelle R Allen; Susan L Lecates; Marielle A Kabbouche; Tracy V Ting; Andrew D Hershey; Scott W Powers
Journal:  Clin J Pain       Date:  2013-12       Impact factor: 3.442

Review 5.  Co-occurrence of pain syndromes.

Authors:  Giannapia Affaitati; Raffaele Costantini; Claudio Tana; Francesco Cipollone; Maria Adele Giamberardino
Journal:  J Neural Transm (Vienna)       Date:  2019-11-29       Impact factor: 3.575

6.  Bidirectional association between migraine and fibromyalgia: retrospective cohort analyses of two populations.

Authors:  I-Wen Penn; Eric Chuang; Tien-Yow Chuang; Cheng-Li Lin; Chia-Hung Kao
Journal:  BMJ Open       Date:  2019-04-08       Impact factor: 2.692

7.  The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine.

Authors:  Münevver Serdaroğlu Beyazal; Ahmet Tüfekçi; Serkan Kırbaş; Mehmet Serhat Topaloğlu
Journal:  Noro Psikiyatr Ars       Date:  2018-05-04       Impact factor: 1.339

8.  Impact of migraine on fibromyalgia symptoms.

Authors:  Maria Adele Giamberardino; Giannapia Affaitati; Paolo Martelletti; Claudio Tana; Andrea Negro; Domenico Lapenna; Martina Curto; Cosima Schiavone; Luisa Stellin; Francesco Cipollone; Raffaele Costantini
Journal:  J Headache Pain       Date:  2016-03-22       Impact factor: 7.277

9.  Symptoms of central sensitization and comorbidity for juvenile fibromyalgia in childhood migraine: an observational study in a tertiary headache center.

Authors:  Marina de Tommaso; Vittorio Sciruicchio; Marianna Delussi; Eleonora Vecchio; Marvita Goffredo; Michele Simeone; Maria Grazia Foschino Barbaro
Journal:  J Headache Pain       Date:  2017-05-30       Impact factor: 7.277

10.  Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.

Authors:  Licia Grazzi; Cristina Tassorelli; Marina de Tommaso; Giulia Pierangeli; Paolo Martelletti; Innocenzo Rainero; Pierangelo Geppetti; Anna Ambrosini; Paola Sarchielli; Eric Liebler; Piero Barbanti
Journal:  J Headache Pain       Date:  2018-10-19       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.